Clearly the trial results didn't meet expectations and he's jumping ship. The update only mentioned the newly bought company rather than the sleep apnea drug. Seems pretty obvious at this point.
IHL Price at posting:
24.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
